Investigators from Baltimore-based Johns Hopkins Kimmel Cancer Center have developed — and made public — a free resource to inform potential immune system responses of pancreatic cancer patients after receiving various combinations of vaccines and immune checkpoint inhibitor drugs.
The study of the tool, called the “Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer,” was published Jan. 12 in Cancer Immunology Research.
The atlas contains data on 260 cytometry profiles from 64 patients who participated in three clinical trials studying pancreatic cancer vaccines and checkpoint inhibitors. Researchers plan to continue adding to the atlas over time, according to a Jan. 12 news release from Johns Hopkins.
Created in collaboration with the Institute for Data Intensive Engineering and Science at Johns Hopkins, the atlas is available online here.
Leave a Reply